0001654954-21-006531.txt : 20210602
0001654954-21-006531.hdr.sgml : 20210602
20210602161149
ACCESSION NUMBER: 0001654954-21-006531
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210601
FILED AS OF DATE: 20210602
DATE AS OF CHANGE: 20210602
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cittadine Andrew
CENTRAL INDEX KEY: 0001863624
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39070
FILM NUMBER: 21989231
MAIL ADDRESS:
STREET 1: C/O 1000 SKOKIE BLVD SUITE 350
CITY: WILMETTE
STATE: IL
ZIP: 60091
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Monopar Therapeutics
CENTRAL INDEX KEY: 0001645469
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 320463781
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1000 SKOKIE BLVD SUITE 350
CITY: WILMETTE
STATE: IL
ZIP: 60091
BUSINESS PHONE: 8473880349
MAIL ADDRESS:
STREET 1: 1000 SKOKIE BLVD SUITE 350
CITY: WILMETTE
STATE: IL
ZIP: 60091
4
1
section16.xml
PRIMARY DOCUMENT
X0306
4
2021-06-01
0001645469
Monopar Therapeutics
MNPR
0001863624
Cittadine Andrew
1000 SKOKIE BLVD, STE 350
WILMETTE
IL
60091
true
Chief Operating Officer
Stock Options
5.76
2021-06-01
4
A
false
70000
0
A
2031-05-31
Common Stock
70000
70000
D
Options vest 6/48ths on November 30, 2021 and 1/48th monthly on the last day of each month thereafter.
/s/ Kim R. Tsuchimoto, Attorney-in-Fact
2021-06-02